Home / Program / 4/27 (Sat) / Symposium 10
Symposium 10:Treatment Strategies for Acute Respiratory Distress Syndrome due to Coronavirus Disease 2019

Acute respiratory distress syndrome (ARDS) is a severe pulmonary disease with high mortality. Besides the traditional protective lung ventilation strategy, recent treatment modalities have shown promising results. High-flow nasal cannula is employed in early ARDS due to Coronavirus disease 2019 (COVID-19). Besides the survival benefits in moderate to severe ARDS, prone positioning has been widely applied for COVID-19 patients, either intubated or non-intubated. Extracorporeal membrane oxygenation (ECMO) has also been used largely in patients with COVID-19 with acute respiratory distress syndrome during the pandemic. This symposium will discuss and summarize the evidence and recommendations about the three aforementioned treatment modalities for ARDS, especially due to COVID-19. The speakers will also share their clinical experiences in treating ARDS patietns.

Date: Saturday, April 27, 2024 | Time: 14:50-16:20 (GMT+8)
Topic Speaker Country / Region
14:50-15:20 High-flow nasal cannula for ARDS Dr. Li-Kuo Kuo Taiwan
15:20-15:50 Prone Positioning for ARDS Dr. Ming-Cheng Chan Taiwan
15:50-16:20 Extracorporeal membrane oxygenation for ARDS Dr. Shu-Min Lin Taiwan